87 related articles for article (PubMed ID: 17285118)
1. Serum interleukin-12 and interleukin-18 levels in patients with oesophageal squamous cell carcinoma.
Diakowska D; Markocka-Maczka K; Grabowski K; Lewandowski A
Exp Oncol; 2006 Dec; 28(4):319-22. PubMed ID: 17285118
[TBL] [Abstract][Full Text] [Related]
2. Serum interleukin-12 and interleukin-18 levels as a tumor marker in patients with esophageal carcinoma.
Tsuboi K; Miyazaki T; Nakajima M; Fukai Y; Masuda N; Manda R; Fukuchi M; Kato H; Kuwano H
Cancer Lett; 2004 Mar; 205(2):207-14. PubMed ID: 15036653
[TBL] [Abstract][Full Text] [Related]
3. Relationship between serum levels of interleukin 6, various disease parameters and malnutrition in patients with esophageal squamous cell carcinoma.
Oka M; Yamamoto K; Takahashi M; Hakozaki M; Abe T; Iizuka N; Hazama S; Hirazawa K; Hayashi H; Tangoku A; Hirose K; Ishihara T; Suzuki T
Cancer Res; 1996 Jun; 56(12):2776-80. PubMed ID: 8665513
[TBL] [Abstract][Full Text] [Related]
4. Serum spleen tyrosine kinase and vascular endothelial growth factor-C levels predict lymph node metastasis of oesophageal squamous cell carcinoma.
Duan L; Ye L; Zhao G; Wu Z; Jin C; Cai X; Li G
Eur J Cardiothorac Surg; 2013 Mar; 43(3):e58-63. PubMed ID: 23242981
[TBL] [Abstract][Full Text] [Related]
5. Relationship between serum levels of soluble interleukin-2 receptor and various disease parameters in patients with squamous cell carcinoma of the esophagus.
Oka M; Hazama S; Takahashi M; Yamamoto K; Abe T; Yoshino S; Hayashi H; Tangoku A
Hepatogastroenterology; 1999; 46(28):2254-9. PubMed ID: 10521976
[TBL] [Abstract][Full Text] [Related]
6. Expression and up-regulation of interleukin-6 in oesophageal carcinoma cells by n-sodium butyrate.
Wang LS; Chow KC; Wu CW
Br J Cancer; 1999 Jul; 80(10):1617-22. PubMed ID: 10408408
[TBL] [Abstract][Full Text] [Related]
7. Clinical significance of serum soluble interleukin 2 receptor-alpha in esophageal squamous cell carcinoma.
Wang LS; Chow KC; Li WY; Liu CC; Wu YC; Huang MH
Clin Cancer Res; 2000 Apr; 6(4):1445-51. PubMed ID: 10778976
[TBL] [Abstract][Full Text] [Related]
8. Elevation of preoperative serum C-reactive protein level is related to poor prognosis in esophageal squamous cell carcinoma.
Shimada H; Nabeya Y; Okazumi S; Matsubara H; Shiratori T; Aoki T; Sugaya M; Miyazawa Y; Hayashi H; Miyazaki S; Ochiai T
J Surg Oncol; 2003 Aug; 83(4):248-52. PubMed ID: 12884238
[TBL] [Abstract][Full Text] [Related]
9. Serum levels of interleukin-6 in patients with primary head and neck squamous cell carcinoma.
Riedel F; Zaiss I; Herzog D; Götte K; Naim R; Hörmann K
Anticancer Res; 2005; 25(4):2761-5. PubMed ID: 16080523
[TBL] [Abstract][Full Text] [Related]
10. Serum levels of interleukin-18 (IL-18) and soluble interleukin-2 receptor (sIL-2R) in lung cancer.
Naumnik W; Chyczewska E; Kovalchuk O; Tałałaj J; Izycki T; Panek B
Rocz Akad Med Bialymst; 2004; 49():246-51. PubMed ID: 15631351
[TBL] [Abstract][Full Text] [Related]
11. Identification of the peripheral blood levels of interleukin-12, interleukin-10, and transforming growth factor-β in patients with laryngeal squamous cell carcinoma.
Günaydın RÖ; Kesikli SA; Kansu E; Hoşal AŞ
Head Neck; 2012 Mar; 34(3):393-7. PubMed ID: 21472884
[TBL] [Abstract][Full Text] [Related]
12. Investigation of interleukin 10, 12 and 18 levels in patients with head and neck cancer.
Jebreel A; Mistry D; Loke D; Dunn G; Hough V; Oliver K; Stafford N; Greenman J
J Laryngol Otol; 2007 Mar; 121(3):246-52. PubMed ID: 17040593
[TBL] [Abstract][Full Text] [Related]
13. Serum adiponectin levels in patients with esophageal cancer.
Yildirim A; Bilici M; Cayir K; Yanmaz V; Yildirim S; Tekin SB
Jpn J Clin Oncol; 2009 Feb; 39(2):92-6. PubMed ID: 19116211
[TBL] [Abstract][Full Text] [Related]
14. Serum biomarkers in head and neck squamous cell cancer.
Kaskas NM; Moore-Medlin T; McClure GB; Ekshyyan O; Vanchiere JA; Nathan CA
JAMA Otolaryngol Head Neck Surg; 2014 Jan; 140(1):5-11. PubMed ID: 24232368
[TBL] [Abstract][Full Text] [Related]
15. High serum soluble E-selectin levels are associated with postoperative haematogenic recurrence in esophageal squamous cell carcinoma patients.
Shimada Y; Maeda M; Watanabe G; Imamura M
Oncol Rep; 2003; 10(4):991-5. PubMed ID: 12792758
[TBL] [Abstract][Full Text] [Related]
16. Serum cross-linked carboxyterminal telopeptide of type I collagen (ICTP) as a prognostic tumor marker in patients with esophageal squamous cell carcinoma.
Nabeya Y; Shimada H; Okazumi S; Matsubara H; Gunji Y; Suzuki T; Ochiai T
Cancer; 2002 Feb; 94(4):940-9. PubMed ID: 11920462
[TBL] [Abstract][Full Text] [Related]
17. Contactin-1 (CNTN-1) overexpression is correlated with advanced clinical stage and lymph node metastasis in oesophageal squamous cell carcinomas.
Liu P; Chen S; Wu W; Liu B; Shen W; Wang F; He X; Zhang S
Jpn J Clin Oncol; 2012 Jul; 42(7):612-8. PubMed ID: 22581910
[TBL] [Abstract][Full Text] [Related]
18. Serum interleukin-12 levels in patients with gastric cancer.
Murakami S; Okubo K; Tsuji Y; Sakata H; Hamada S; Hirayama R
Surg Today; 2004; 34(12):1014-9. PubMed ID: 15580384
[TBL] [Abstract][Full Text] [Related]
19. [Postoperative Th1 and Th2 type cytokine changes in patients with esophageal squamous cell carcinoma and their clinical significance].
Wei YC; Hu FB; Shen Y; Xu LH; Lin LS
Di Yi Jun Yi Da Xue Xue Bao; 2004 Nov; 24(11):1271-3. PubMed ID: 15567776
[TBL] [Abstract][Full Text] [Related]
20. Proinflammatory interferon-gamma--inducing monokines (interleukin-12, interleukin-18, interleukin-15)--serum profile in patients with systemic lupus erythematosus.
Robak E; Robak T; Wozniacka A; Zak-Prelich M; Sysa-Jedrzejowska A; Stepien H
Eur Cytokine Netw; 2002; 13(3):364-8. PubMed ID: 12231481
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
